Purpose: Previous epidemiologic studies have demonstrated an association of low serum 25-hydroxyvitamin D levels with the development and progression of osteoarthritis (OA) of the hip and knee. Potential pathophysiologic mechanisms include effects on chondrocyte metabolism and immune responses as well as associations with low bone mineral density. A prior genome-wide association study (GWAS) demonstrated associations of single nucleotide polymorphisms (SNPs) in genes involved in vitamin D metabolism with serum 25(OH)D insufficiency (Lancet 2010;376:180-8). The present analysis focused on whether SNPs in genes within the vitamin D metabolism pathway are associated with radiographic knee OA. Methods: We tested for associations between radiographic knee OA (RKOA) and 271 SNPs falling within 6 Vitamin D metabolism pathway genes (CYP2R1; CYP24A1, CYP27A1, CYP27B1, GC, VDR) in 3286 participants from the Osteoarthritis Initiative (OAI). Cases (N = 2209) had at least one knee with definite osteophytes irrespective of the presence of joint space narrowing (equivalent to Kellgren-Lawrence [KL] grade 2 of higher). Controls (N = 1077) had both knees free of both osteophytes and joint space narrowing (equivalent to KL grade 0). The candidate gene SNPs were genotyped on the Illumina 2.5M platform as part of the GWAS of OAI participants. Odds ratios for the association of individual SNPs and RKOA were estimated from logistic regression analyses adjusted for age and gender; analyses were conducted separately for Caucasians and African-Americans. We estimated that the sample size would provide 80% power to detect associations with odds ratios of 1.25-1.37 for SNPs with minor allele frequencies of 0.10 to 0.50 (a = 0.001). Results: Demographic features of cases and controls are shown in Table 1 . In single SNP analysis of 2,669 Caucasian subjects, RKOA was nominally associated with 2 SNPs in CYP2R1 (p < 0.05), 1 SNP in VDR (p < 0.02), and 1 SNP in CYP24A1 (p < 0.02). Using a gene-wise permutation test that accounted for correlations among SNPs and the number of SNPs tested within each gene, none of these associations was smaller than what would have been expected by chance. In single SNP analysis of 617 African-American subjects, RKOA was nominally associated with 2 SNPs in CYP27A1 (p < 0.03), 1 SNP in VDR (p < 0.03), and 2 SNPs in CYP24A1 (p < 0.03). After performing the gene-wise permutation test, there remained weak evidence that the association observed between CYP24A1 SNP20-52212617 and RKOA (p = 0.007) was smaller than would have been observed by chance after taking into account the multiple testing within this gene (p = 0.06).
Purpose:
To chart the genes and processes involved in the breakdown of cartilage during osteoarthritis (OA) in a genome wide expression approach of a considerable number (N = 33) of matched OA affected and preserved cartilage samples using microarrays. Methods: For 33 patients of the research osteoarthritis and articular cartilage (RAAK) study (mean age 66.2, range 54-80) we collected paired cartilage samples at joint replacement surgeries. Affected (near lesion) areas were matched by preserved (distant from lesion) areas within each single joint. We included both hip (N = 22) and knee (N = 11) replacements. By use of microscopic assessment a scoring of the cartilage damage was made according to Mankin which takes both cellular and matrix features of OA into account. RNA was isolated by use of cryogenic disintegration of the cartilage followed by Qiagen column extraction and checked for quality (RIN > 8.0) and quantity by lab-ona-chip techniques before applying the standard protocol for Illumina microarray measurements on the HT12-v3-microarrays. After microarray analyses all 33 sample pairs passed basic quality control. Analysis of the data was performed using 'R' and the Limma package identifying the most significantly up-or downregulated single genes, corrected for multiple testing (Holm's method). Results: Although for some samples the preserved areas did show signs of OA damage, the Mankin grading for cartilage indicated overall less damage within the preserved areas as compared to the matched affected cartilage areas. In total, we detected 206 probes (representing 183 genes) which were differentially expressed with a Holm adjusted P-value <0.05, irrespective of fold changes of expression. Amongst these were genes associated to inflammation, the complement system, development, matrix associated genes and several genes involved in neuronal processes. When we prioritized the data for genes that showed a fold change of at least 2, we found the expression to be decreased for 5 genes and increased for 15 genes in affected as compared to matched preserved cartilage (23 corresponding probes). The markedly up-regulated genes belong to pathways which are the usual suspects for involvement in OA being; inflammation (prostaglandin E synthase (PTGES), chemokine ligand 14 (CXCL14)) and developmental or matrix associated genes (osteopontin (SPP1), frizzled related protein (FRZB), collagen type IX alpha 1 (COL9A1)). More remarkable, we observed extensive and significant upregulation of the nerve growth factor (NGF) gene. Conclusions: This is the first analysis of micro-array expression data of a large number of OA affected cartilage samples matched by preserved cartilage from the same joint. We show differential expression 183 genes reflecting several processes that may mark the ongoing OA process in human cartilage. Possibly, amongst these genes are potent therapeutic targets which may be targeted to stop the process of cartilage breakdown.
